News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
268,242 Results
Type
Article (14256)
Company Profile (281)
Press Release (253705)
Multimedia
Podcasts (48)
Webinars (7)
Section
Business (79569)
Career Advice (152)
Deals (13239)
Drug Delivery (35)
Drug Development (50468)
Employer Resources (31)
FDA (5726)
Job Trends (5134)
News (144485)
Policy (10032)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Biotech Bay Standard (10)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (3)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (916)
Accelerated approval (2)
Adcomms (12)
Allergies (52)
Alliances (21683)
ALS (64)
Alzheimer's disease (848)
Antibody-drug conjugate (ADC) (100)
Approvals (5754)
Artificial intelligence (124)
Autoimmune disease (18)
Automation (5)
Bankruptcy (105)
Best Places to Work (4560)
BIOSECURE Act (6)
Biosimilars (43)
Biotechnology (232)
Bladder cancer (58)
Brain cancer (20)
Breast cancer (155)
Cancer (1479)
Cardiovascular disease (116)
Career advice (133)
Career pathing (2)
CAR-T (117)
Cell therapy (331)
Cervical cancer (8)
Clinical research (41091)
Collaboration (542)
Compensation (258)
Complete response letters (13)
COVID-19 (1034)
CRISPR (42)
C-suite (164)
Cystic fibrosis (76)
Data (1523)
Denatured (11)
Depression (30)
Diabetes (139)
Diagnostics (1301)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (85)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (90)
Earnings (29842)
Editorial (18)
Employer branding (4)
Employer resources (29)
Events (48647)
Executive appointments (464)
FDA (6424)
Featured Employer (30)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (498)
Gene editing (97)
Generative AI (10)
Gene therapy (254)
GLP-1 (366)
Government (1080)
Grass and pollen (2)
Guidances (22)
Healthcare (6601)
Huntington's disease (22)
IgA nephropathy (25)
Immunology and inflammation (92)
Indications (20)
Infectious disease (1099)
Inflammatory bowel disease (114)
Inflation Reduction Act (8)
Influenza (19)
Intellectual property (67)
Interviews (17)
IPO (7278)
IRA (11)
Job creations (861)
Job search strategy (127)
Kidney cancer (7)
Labor market (5)
Layoffs (209)
Leadership (3)
Legal (1386)
Liver cancer (33)
Lung cancer (205)
Lymphoma (101)
Machine learning (3)
Management (7)
Manufacturing (140)
MASH (53)
Medical device (2602)
Medtech (2603)
Mergers & acquisitions (6292)
Metabolic disorders (390)
Multiple sclerosis (53)
NASH (13)
Neurodegenerative disease (68)
Neuropsychiatric disorders (25)
Neuroscience (1257)
NextGen: Class of 2025 (2023)
Non-profit (854)
Northern California (1702)
Now hiring (21)
Obesity (194)
Opinion (102)
Ovarian cancer (63)
Pain (43)
Pancreatic cancer (56)
Parkinson's disease (121)
Partnered (8)
Patents (130)
Patient recruitment (78)
Peanut (35)
People (25662)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14515)
Phase II (19112)
Phase III (12083)
Pipeline (808)
Policy (45)
Postmarket research (852)
Preclinical (6143)
Press Release (30)
Prostate cancer (62)
Psychedelics (35)
Radiopharmaceuticals (213)
Rare diseases (292)
Real estate (1419)
Recruiting (12)
Regulatory (8641)
Reports (15)
Research institute (939)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (5)
RSV (10)
Schizophrenia (60)
Series A (98)
Series B (63)
Service/supplier (1)
Sickle cell disease (40)
Southern California (1487)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1975)
State (1)
Stomach cancer (4)
Supply chain (23)
Tariffs (9)
The Weekly (36)
United States (13269)
Vaccines (213)
Venture capitalists (32)
Weight loss (110)
Women's health (15)
Worklife (2)
Date
Today (91)
Last 7 days (526)
Last 30 days (1516)
Last 365 days (19574)
2025 (6281)
2024 (20553)
2023 (22429)
2022 (26847)
2021 (27820)
2020 (23363)
2019 (16248)
2018 (11753)
2017 (13746)
2016 (11844)
2015 (14354)
2014 (10394)
2013 (7486)
2012 (7532)
2011 (7615)
2010 (7432)
Location
Africa (148)
Alabama (43)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17331)
Australia (2936)
California (3862)
Canada (1141)
China (360)
Colorado (149)
Connecticut (151)
Delaware (102)
Europe (37259)
Florida (465)
Georgia (116)
Idaho (17)
Illinois (232)
India (10)
Indiana (91)
Iowa (2)
Japan (75)
Kansas (62)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (473)
Massachusetts (3082)
Michigan (70)
Minnesota (145)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (967)
New Mexico (12)
New York (1045)
North Carolina (553)
North Dakota (5)
Northern California (1702)
Ohio (112)
Oklahoma (9)
Oregon (21)
Pennsylvania (741)
Puerto Rico (6)
Rhode Island (19)
South America (208)
South Carolina (4)
Southern California (1487)
Tennessee (25)
Texas (448)
Utah (53)
Virginia (79)
Washington D.C. (30)
Washington State (351)
Wisconsin (15)
268,242 Results for "jasper therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Jasper Therapeutics to Present at Upcoming March 2025 Investor Conferences
February 26, 2025
·
5 min read
Press Releases
Jasper Therapeutics to Present at the Oppenheimer Healthcare Life Sciences Conference
February 4, 2025
·
4 min read
Press Releases
Jasper Therapeutics Announces Late-Breaking Briquilimab Presentation at the American Academy of Dermatology (AAD) Annual Meeting
March 3, 2025
·
5 min read
Immunology and inflammation
Jasper Posts Promising Mid-Stage Data for Urticaria Drug, Eyes Challenge to Blockbusters
With positive results for patients with the chronic skin condition, Jasper Therapeutics’ briquilimab is looking to take on Novartis and Genentech’s Xolair as well as Sanofi and Regeneron’s Dupixent.
October 15, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Jasper Therapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Corporate Update
February 27, 2025
·
11 min read
Biotech Bay
Jasper Therapeutics to Present at the Oppenheimer Novel Targets in Immunology Summit
Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper) today announced today announced that its management will present at the Oppenheimer Novel Targets in Immunology Summit, to be held on Monday, June 24, 2024, in New York City.
June 17, 2024
·
4 min read
Press Releases
Jasper Therapeutics Presents Clinical and Preclinical Briquilimab Data at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
March 3, 2025
·
9 min read
Press Releases
Jasper Therapeutics Announces Briquilimab Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
February 10, 2025
·
6 min read
Business
Jasper Therapeutics Announces Appointment of Svetlana Lucas Ph.D., to its Board of Directors
Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven diseases such as chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU) and asthma, today announced the appointment of Svetlana Lucas, Ph.D., to Jasper’s Board of Directors (the Board), effective as of June 18, 2024.
June 19, 2024
·
6 min read
Biotech Bay
Jasper Therapeutics to Present at Upcoming Investor Conferences in May 2024
Jasper Therapeutics, Inc. announced that its management will present at the following upcoming investor conferences in May.
May 7, 2024
·
4 min read
1 of 26,825
Next
